…
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Acadia Healthcare operates inpatient and outpatient behavioral health facilities in the U.S. and select international markets, offering psychiatric hospitals, residential treatment, outpatient clinics and medication-assisted substance use disorder services. Long-term growth may be supported by rising demand for mental-health and addiction treatment, consolidation opportunities and expansion of managed services; investors may find scale and diversified, recurring payer-derived revenue attractive.
Key risks include exposure to reimbursement and regulatory changes, integration and execution risk from acquisition-driven growth, operational pressure from workforce shortages, and elevated leverage that could constrain financial flexibility.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1065.94M | 341.88M | -25.36M | 374.14M | 275.76M |
| Minority interest | -10.85M | -8.87M | -6.00M | -6.89M | 4.93M |
| Net income | -1102.77M | 255.61M | -21.67M | 273.14M | 190.63M |
| Selling general administrative | 195.47M | 189.71M | 176.01M | 203.47M | 175.26M |
| Selling and marketing expenses | - | - | 1618.88M | - | - |
| Gross profit | 583.44M | 711.98M | 682.61M | 1116.77M | 979.89M |
| Reconciled depreciation | 189.25M | 149.59M | 127.11M | 117.77M | 106.72M |
| Ebit | -927.08M | 458.25M | 56.77M | 443.90M | 352.75M |
| Ebitda | -737.83M | 607.84M | 189.11M | 561.67M | 459.47M |
| Depreciation and amortization | 189.25M | 149.59M | 132.35M | 117.77M | 106.72M |
| Non operating income net other | - | - | - | - | -24.65M |
| Operating income | 387.96M | 522.28M | 506.60M | 443.90M | 414.47M |
| Other operating expenses | 2924.80M | 2631.69M | 2422.14M | 2142.70M | 1899.92M |
| Interest expense | 138.86M | 116.37M | 82.12M | 69.76M | 76.99M |
| Tax provision | 25.98M | 77.39M | -4.98M | 94.11M | 67.56M |
| Net interest income | -138.86M | -116.37M | -81.06M | -69.76M | -76.99M |
| Non recurring | - | - | - | - | 37.07M |
| Income tax expense | 25.98M | 77.39M | -9.70M | 94.11M | 67.56M |
| Total revenue | 3312.77M | 3153.96M | 2928.74M | 2610.40M | 2314.39M |
| Total operating expenses | 195.47M | 189.71M | 176.01M | 649.07M | 565.41M |
| Cost of revenue | 2729.33M | 2441.98M | 2246.13M | 1493.63M | 1334.51M |
| Total other income expense net | -1453.91M | -180.40M | -531.96M | -72.10M | -120.81M |
| Discontinued operations | - | - | - | - | -12.64M |
| Net income from continuing ops | -1091.92M | 264.48M | -12.27M | 280.03M | 208.20M |
| Net income applicable to common shares | - | - | - | 273.14M | 190.63M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 5527.45M | 5956.91M | 5358.84M | 4987.90M | 4768.08M |
| Intangible assets | 96.67M | 70.00M | 73.28M | 76.04M | 70.14M |
| Other current assets | 130.05M | 73.56M | 61.10M | 86.04M | 79.89M |
| Total liab | 3386.90M | 2766.08M | 2471.18M | 2086.92M | 2185.20M |
| Total stockholder equity | 1948.96M | 3073.72M | 2781.97M | 2812.73M | 2517.49M |
| Deferred long term liab | - | - | - | - | 74.37M |
| Other current liab | 321.30M | 231.49M | 671.01M | 229.24M | 233.97M |
| Common stock | 0.91M | 0.92M | 0.91M | 0.90M | 0.89M |
| Capital stock | 0.91M | 0.92M | 0.91M | 0.90M | 0.89M |
| Retained earnings | -765.84M | 387.33M | 131.72M | 153.39M | -119.75M |
| Other liab | - | - | - | 206.76M | 184.87M |
| Good will | 1296.34M | 2264.85M | 2225.96M | 2222.80M | 2199.94M |
| Other assets | - | - | - | 95.65M | 98.05M |
| Cash | 133.24M | 76.31M | 100.07M | 97.65M | 133.81M |
| Total current liabilities | 525.19M | 577.92M | 885.78M | 388.33M | 404.86M |
| Current deferred revenue | 2.81M | 1.69M | 2.17M | 6.65M | 30.37M |
| Net debt | 2521.65M | 2008.98M | 1410.66M | 1431.03M | 1503.60M |
| Short term debt | 50.69M | 103.37M | 56.48M | 47.71M | 41.94M |
| Short long term debt | 28.44M | 76.82M | 29.22M | 21.25M | 18.59M |
| Short long term debt total | 2654.89M | 2085.29M | 1510.73M | 1528.68M | 1637.41M |
| Other stockholder equity | 2713.90M | 2685.46M | 2649.34M | 2658.44M | 2636.35M |
| Property plant equipment | - | - | - | 2087.28M | 1904.92M |
| Total current assets | 814.14M | 577.49M | 596.00M | 506.12M | 495.03M |
| Net tangible assets | - | - | - | 513.88M | 247.41M |
| Net receivables | 545.16M | 421.98M | 429.53M | 322.44M | 281.33M |
| Long term debt | 2471.53M | 1880.09M | 1342.55M | 1364.54M | 1478.63M |
| Inventory | 5.69M | 5.65M | 5.30M | 5.09M | 4.79M |
| Accounts payable | 150.40M | 232.70M | 156.13M | 104.72M | 98.58M |
| Common stock total equity | - | - | - | - | 0.89M |
| Retained earnings total equity | - | - | - | - | -119.75M |
| Non currrent assets other | 50.95M | 43.24M | 43.85M | 92.70M | 94.97M |
| Non current assets total | 4713.31M | 5379.42M | 4762.84M | 4481.78M | 4273.05M |
| Capital lease obligations | 144.21M | 128.38M | 128.07M | 142.89M | 141.18M |
| Long term debt total | - | - | - | - | 1478.63M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -736.48M | -379.07M | -305.83M | -84.80M |
| Change to liabilities | - | - | - | 5.17M | 6.16M |
| Total cashflows from investing activities | -547.58M | -736.48M | - | -305.83M | 1017.63M |
| Net borrowings | 550.96M | 583.67M | - | -113.59M | -1640.90M |
| Total cash from financing activities | 472.61M | 583.02M | -62.70M | -110.90M | -1641.06M |
| Change to operating activities | - | - | - | -32.55M | -52.12M |
| Net income | -1091.92M | 264.48M | -21.67M | 280.03M | 195.56M |
| Change in cash | 56.94M | -23.77M | 2.42M | -36.16M | -244.88M |
| Begin period cash flow | 76.31M | 100.07M | 97.65M | 133.81M | 378.70M |
| End period cash flow | 133.24M | 76.31M | 100.07M | 97.65M | 133.81M |
| Total cash from operating activities | 131.90M | 129.69M | 462.34M | 380.57M | 374.48M |
| Depreciation | 189.25M | 149.59M | 132.35M | 117.77M | 106.72M |
| Other cashflows from investing activities | -0.09M | 7.46M | - | -7.25M | 1397.97M |
| Dividends paid | - | - | - | 17.79M | 1.59M |
| Change to inventory | - | - | - | - | -13.99M |
| Change to account receivables | -75.02M | -2.33M | -39.01M | -41.98M | 2.45M |
| Sale purchase of stock | -50.03M | -8.55M | -52.53M | -17.79M | -5.73M |
| Other cashflows from financing activities | -9.69M | 7.90M | -46.45M | 2.69M | 5.58M |
| Change to netincome | - | - | - | 55.75M | 116.56M |
| Capital expenditures | 571.81M | 690.38M | 424.13M | 296.15M | 244.81M |
| Change receivables | - | - | - | - | 2.45M |
| Cash flows other operating | - | - | - | - | -46.93M |
| Cash and cash equivalents changes | - | - | - | - | -248.95M |
| Change in working capital | -8.67M | -405.88M | 6.63M | -69.35M | -43.50M |
| Stock based compensation | 31.71M | 37.11M | 32.29M | 29.64M | 37.53M |
| Other non cash items | 1010.44M | 16.68M | 406.72M | 5.94M | 66.40M |
| Free cash flow | -439.91M | -560.69M | 38.21M | 84.42M | 129.67M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company Inc |
1.74 4.69% |
38.73 | - | 14.97 | 0.76 | 1.32 | 1.48 | 9.47 |
| HCA HCA Healthcare, Inc. |
8.00 1.62% |
502.99 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
5.54 1.95% |
288.87 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.27 1.86% |
14.79 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
0.29 5.59% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
4020 Aspen Grove Drive, Franklin, TN, United States, 37067
615 861 6000
25000
| Name | Title | Year Born |
|---|---|---|
| Mr. David M. Duckworth | Chief Financial Officer | 1980 |
| Mr. John S. Hollinsworth | Exec. VP of Operations | 1964 |
| Mr. Christopher L. Howard | Exec. VP, Gen. Counsel & Sec. | 1967 |
| Mr. Laurence L. Harrod | Exec. VP of Fin. | 1957 |
| Mr. Christopher Howal Hunter | CEO & Director | 1968 |
| Gretchen Hommrich | VP of Investor Relations | NA |
| Mr. Andrew Honeybone | Sr. VP & Chief HR Officer | NA |
| Ms. Isa Diaz | Sr. VP of Strategic Affairs | NA |
| Dr. Michael Genovese J.D., M.D. | Chief Medical Officer | NA |
| Mr. David M. Keys CFA | Chief Devel. Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.